Abstract
The effect of verapamil on the cardiomyopathic hamster is wellknown from the basic works of Loßnitzer (6–9). It is not known, however, whether different calcium-antagonists have the same cardioprotective potency. In this study we analyzed the effect of bepridil, on the cardiomyopathic hamster. Bepridil is shown to be a calcium antagonistic drug (10) with documented antianginal (1) in humans efficacy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Canicave JC, Den J, Jacq Z, Paillet R (1980) Therapie 35: 607
Factor S, Minase T, Cho S, Dominitz R, Sonnenblick E (1985) Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis. Circulation 66: 342–354
Fleckenstein A, Janke J, Döring HJ, Leder O (1971) Die intracelluläre Überladung mit Calcium als entscheidender Kausalfaktor bei der Entstehung nicht coronarogener Myokardnekrosen. Verh Dtsch Ges Kreislaufforsch 37: 345–353
Fleckenstein A, Janke J, Döring HJ, Pachinger O (1973) Ca overload the determinant factor in the production of catecholamine-induced myocardial lesion. In: Bajusz E, Rona G (eds) Cardiomyopathies. Recent in the Study of Cardiac Structural Metabolism. Advances Vol 2. University Park Press, Baltimore—London—Tokyo, pp 455–466
Fleckenstein A, Frey M, Keidel JJ (1982) Prevention by Verapamil of Isoproterenol-induced hypertrophie cardiomyopathy in rats. In: M Kaltenbach, S Epstein (eds) Hypertrophie cardiomyopathy. Springer Verlag, Berlin—Heidelberg-New York, pp 113–120
Loßnitzer K, Steinhard B, Grewe N, Stauch M (1975) Charakteristische Elektrolytveränderungen bei der erblichen Kardiomyopathie des Syrischen Goldhamsters (Stamm Bio 8262). Basic Res Cardiol 70: 508–520
Loßnitzer K, Konrad A, Zeger D, Mohr W (1982) Prevention of myocardial cell necrosis in the Syrian hamster. Results of long-term treatment. In: M Kaltenbach, S Epstein (eds) Hypertrophie Cardiomyopathy. Springer Verlag, Berlin—Heidelberg—New York, pp 99–114
Loßnitzer K (1975) Genetic Induction of a Cardiomyopathy. In: Born GVR, Eichler O, Farah A, Herken H, Welch AD (eds) Handbuch der experimentellen Pharmakologie. Vol XVI/3, Springer Verlag, Berlin—Heidelberg—New York, pp 309–344
Mohr W, LoBnitzer K (1974) Morphologische Untersuchungen an Hamstern des Stammes Bio 8262 mit erblicher Myopathie und Kardiomyopathie. Beitr Path 153: 178–193
Murphy KMM; Gould RJ, Largent BJ, Snyder SH (1983) Proc Natl Acad Sci USA 80: 860
Weibel E, Kistler GS, Scherle WF (1966) Practical stereological methods for morphometric cytology. J Cell Biol 30: 23–38
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Kunkel, B., Hofmann, U., Mutschler, M. (1988). Comparison of verapamil and bepridil in the therapy of familiar cardiomyopathy of the Syrian hamster. In: Kaltenbach, M., Hopf, R., Kunkel, B. (eds) New Aspects of Hypertrophic Cardiomyopathy. Steinkopff. https://doi.org/10.1007/978-3-642-85369-2_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-85369-2_26
Publisher Name: Steinkopff
Print ISBN: 978-3-642-85371-5
Online ISBN: 978-3-642-85369-2
eBook Packages: Springer Book Archive